Sonic Fund II’s Adverum Biotechnologies ADVM Stock Holding History

Sonic Fund II’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-655,207	Closed	-$6.22M	–	1
2022 Q3	$6.22M	Hold	655,207	–	–	4.23%	9
2022 Q2	$7.86M	Hold	655,207	–	–	4.8%	8
2022 Q1	$8.58M	Hold	655,207	–	–	4.82%	8
2021 Q4	$11.5M	Hold	655,207	–	–	7.47%	3
2021 Q3	$14.2M	Hold	655,207	–	–	8.03%	2
2021 Q2	$22.9M	Hold	655,207	–	–	10.45%	1
2021 Q1	$64.6M	Buy	655,207 +145,028	+28%	+$17.4M	26.69%	1
2020 Q4	$55.3M	Buy	510,179 +99,192	+24%	+$12.3M	26.73%	1
2020 Q3	$42.3M	Sell	410,987 -249	-0.1%	-$37.3K	29.76%	1
2020 Q2	$85.9M	Hold	411,236	–	–	42.72%	1
2020 Q1	$40.2M	Buy	411,236 +6,915	+2%	+$806K	34.81%	1
2019 Q4	$46.6M	Buy	+404,321	New	+$35.6M	47.83%	1

Other funds holding ADVM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

SGL

Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sonic Fund II's ADVM Position: Q4 2022 in Review

Sonic Fund II sold out of Adverum Biotechnologies (ADVM) in Q4 2022, closing a stake of 655,207 shares — an estimated $6.22M sold.

Sonic Fund II first reported a position in ADVM in Q4 2019 and held it in 12 quarters. The position peaked at $85.9M in Q2 2020. 59 funds tracked by Wall St. Rank hold ADVM as of Q4 2022.

Sonic Fund II reported no remaining Adverum Biotechnologies position as of Q4 2022 after selling out during the quarter.
Sonic Fund II sold 655,207 Adverum Biotechnologies shares in Q4 2022, an estimated $6.22M.
Sonic Fund II first reported a position in Adverum Biotechnologies in Q4 2019 and held it in 12 quarters.
Sonic Fund II's Adverum Biotechnologies position peaked at $85.9M in Q2 2020.
59 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2022.

Based on Sonic Fund II's 13F filing for Q4 2022.